Amplifications of TAOS1 and EMS1 genes in oral carcinogenesis: association with clinicopathological features

Oral Oncology

Volumn 43, Issue 5, 2007, Pages 508-514

  Xia, Juan ^a,b   Chen, Qianming ^a   Li, Bingqi ^a   Zeng, Xin ^a  

^a SICHUAN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

EMS1; Oral; Premalignant lesion; Squamous cell carcinoma; TAOS1

Indexed keywords

DNA;

ADULT; ARTICLE; CHROMOSOME 11Q; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; DYSPLASIA; EMS1 GENE; FEMALE; GENE; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOPLAKIA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MOUTH CANCER; MOUTH CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TAOS1 GENE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CORTACTIN; FEMALE; GENE AMPLIFICATION; HUMANS; LEUKOPLAKIA, ORAL; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM PROTEINS; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 34147176609     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2006.05.008     Document Type: Article

References (26)

1. Lin M., Smith L.T., Smiraglia D.J., Kazhiyur-Mannar R., Lang J.C., Schuller D.E., et al. DNA copy number gains in head and neck squamous cell carcinoma. Oncogene 25 (2006) 1424-1433
2. Hui A.B., Or Y.Y., Takano H., Tsang R.K., To K.F., Guan X.Y., et al. Array-based comparative genomic hybridization analysis identified cyclin D1 as a target oncogene at 11q13.3 in nasopharyngeal carcinoma. Cancer Res 65 (2005) 8125-8133
3. Zaharieva B.M., Simon R., Diener P.A., Ackermann D., Maurer R., Alund G., et al. High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer. J Pathol 201 (2003) 603-608
4. Meredith S.D., Levine P.A., Burns J.A., Gaffey M.J., Boyd J.C., Weiss L.M., et al. Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Association with poor prognosis. Arch Otolaryngol Head Neck Surg 121 (1995) 790-794
5. Schuuring E. The involvement of the chromosome 11q13 region in human malignancies: cyclin D1 and EMS1 are two new candidate oncogenes-a review. Gene 159 (1995) 83-96
6. Huang X., Gollin S.M., Raja S., and Godfrey T.E. High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells. Proc Natl Acad Sci USA 99 (2002) 11369-11374
7. Campbell D.H., Sutherland R.L., and Daly R.J. Signaling pathways and structural domains required for phosphorylation of EMS1/cortactin. Cancer Res 59 (1999) 5376-5385
8. Schuuring E., van Damme H., Schuuring-Scholtes E., Verhoeven E., Michalides R., Geelen E., et al. Characterization of the EMS1 gene and its product, human Cortactin. Cell Adhes Commun 6 (1998) 185-209
9. Scully C., Field J.K., and Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control. Oral Oncol 36 (2000) 256-263
10. Freier K., Sticht C., Hofele C., Flechtenmacher C., Stange D., Puccio L., et al. Recurrent coamplification of cytoskeleton-associated genes EMS1 and SHANK2 with CCND1 in oral squamous cell carcinoma. Genes Chromosomes Cancer 45 (2006) 118-125
11. Rodrigo J.P., Garcia L.A., Ramos S., Lazo P.S., and Suarez C. EMS1 gene amplification correlates with poor prognosis in squamous cell carcinomas of the head and neck. Clin Cancer Res 6 (2000) 3177-3182
12. Patel A.M., Incognito L.S., Schechter G.L., Wasilenko W.J., and Somers K.D. Amplification and expression of EMS-1 (cortactin) in head and neck squamous cell carcinoma cell lines. Oncogene 12 (1996) 31-35
13. Liu S.C., and Klein-Szanto A.J.P. Markers of proliferation in normal and leukoplakic oral epithelia. Oral Oncol 36 (2000) 145-151
14. Zhang L., and Rosin M.P. Loss of heterozygosity: a potential tool in management of oral premalignant lesions?. J Oral Pathol Med 30 (2001) 513-520
15. Mehrotra R., Gupta A., Singh M., and Ibrahim R. Application of cytology and molecular biology in diagnosing premalignant or malignant oral lesions. Mol Cancer 5 (2006) 11
16. Fujii M., Ishiguro R., Yamashita T., and Tashiro M. Cyclin D1 amplification correlates with early recurrence of squamous cell carcinoma of the tongue. Cancer Lett 172 (2001) 187-192
17. Mineta H., Miura K., Takebayashi S., Ueda Y., Misawa K., Harada H., et al. Cyclin D1 overexpression correlates with poor prognosis in patients with tongue squamous cell carcinoma. Oral Oncol 36 (2000) 194-198
18. Miyamoto R., Uzawa N., Nagaoka S., Nakakuki K., Hirata Y., and Amagasa T. Potential marker of oral squamous cell carcinoma aggressiveness detected by fluorescence in situ hybridization in fine-needle aspiration biopsies. Cancer 95 (2002) 2152-2159
19. Scully C., Sudbo J., and Speight P.M. Progress in determining the malignant potential of oral lesions. J Oral Pathol Med 32 (2003) 251-256
20. Schliephake H. Prognostic relevance of molecular markers of oral cancer-a review. Int J Oral Maxillofac Surg 32 (2003) 233-245
21. Takes R.P., Baatenburg de Jong R.J., Schuuring E., Hermans J., Vis A.A., Litvinov S.V., et al. Markers for assessment of nodal metastasis in laryngeal carcinoma. Arch Otolaryngol Head Neck Surg 123 (1997) 412-419
22. Muller D., Millon R., Velten M., Bronner G., Jung G., Engelmann A., et al. Amplification of 11q13 DNA markers in head and neck squamous cell carcinomas: correlation with clinical outcome. Eur J Cancer 33 (1997) 2203-2210
23. Hermsen M., Alonso Guervos M., Meijer G., van Diest P., Suarez Nieto C., Marcos C.A., et al. Chromosomal changes in relation to clinical outcome in larynx and pharynx squamous cell carcinoma. Cell Oncol 27 (2005) 191-198
24. Myo K., Uzawa N., Miyamoto R., Sonoda I., Yuki Y., and Amagasa T. Cyclin D1 gene numerical aberration is a predictive marker for occult cervical lymph node metastasis in TNM Stage I and II squamous cell carcinoma of the oral cavity. Cancer 104 (2005) 2709-2716
25. Rodolico V., Aragona F., Cabibi D., Di Bernardo C., Di Lorenzo R., Gebbia N., et al. Overexpression of cyclin D1 and interaction between p27Kip1 and tumour thickness predict lymph node metastases occurrence in lower lip squamous cell carcinoma. Oral Oncol 41 (2005) 268-275
26. van Damme H., Brok H., Schuuring-Scholtes E., and Schuuring E. The redistribution of cortactin into cell-matrix contact sites in human carcinoma cells with 11q13 amplification is associated with both overexpression and post-translational modification. J Biol Chem 272 (1997) 7374-7380